Usmangani Chhalotiya | Analytical Method Development | Academic Visionary Discovery Award

Published on by Global Scholar Awards

Dr. Usmangani Chhalotiya | Analytical Method Development | Academic Visionary Discovery Award

Associate Professor | Indukaka Ipcowala College of Pharmacy | India

Dr. Usmangani K. Chhalotiya is an accomplished pharmaceutical scientist and academician specializing in Quality Assurance, Analytical Method Development, and Bioanalytical Validation, with over a decade of impactful contributions to pharmaceutical research and education. He earned his Ph.D. in Pharmaceutical Sciences from Sardar Patel University, V.V. Nagar, in 2013, following his M. Pharm. in Quality Assurance (2008) and B. Pharm. (2006) from the same university, establishing a strong foundation in pharmaceutical sciences. Currently serving as Associate Professor at Indukaka Ipcowala College of Pharmacy, CVM University, Anand, Gujarat since 2009, he has guided 22 M. Pharm. dissertations, mentored Ph.D. scholars, coordinated institutional Ph.D. programs, and actively contributed to curriculum development as a member of the Board of Studies. His research interests span impurity profiling, impurity characterization using LC-MS/MS, NMR, IR, and the development of robust analytical methods aligned with ICH and cGMP guidelines, ensuring scientific rigor and industrial relevance. He is proficient in chromatographic techniques (HPLC, HPTLC, GC), bioanalytical method validation, and advanced sample preparation approaches, with a strong command of data interpretation and literature analysis. Dr. Chhalotiya has published more than 60 papers in reputed peer-reviewed journals indexed in Scopus and IEEE, co-authored a book, delivered expert talks at state and national conferences, and secured research grants from GUJCOST, GSBTM, and GSPC for organizing seminars, workshops, and conferences. His achievements include receiving the prestigious P. D. Sethi Award (2013–2021) for his outstanding contributions to analytical chemistry research. He has also served as ISO system representative, PCI portal coordinator, and industry–academic collaborator, reflecting his leadership in academia and community service. With dedication to advancing pharmaceutical sciences, mentoring young researchers, and expanding global collaborations, Dr. Chhalotiya continues to demonstrate scholarly excellence and leadership potential. 406 Citations by 370 documents | 61 Documents | 12 h-index.

Profile: Google Scholar | Scopus | ORCID

Featured Publications

  1. Choudhary, D. R., Patel, V. A., Chhalotiya, U. K., Patel, H. V., & Kundawala, A. J. (2012). Development and characterization of pharmacokinetic parameters of fast-dissolving films containing levocetirizine. Scientia Pharmaceutica, 80(3), 779. Cited by: 71

  2. Chhalotiya, U. K., Bhatt, K. K., Shah, D. A., & Baldania, S. L. (2010). Development and validation of a stability-indicating RP-HPLC method for duloxetine hydrochloride in its bulk and tablet dosage form. Scientia Pharmaceutica, 78(4), 857. Cited by: 50

  3. Patel, K. P., Chhalotiya, U. K., Kachhiya, H. M., & Patel, J. K. (2020). A new RP–HPLC method for simultaneous quantification of perindopril erbumine, indapamide, and amlodipine besylate in bulk and pharmaceutical dosage form. Future Journal of Pharmaceutical Sciences, 6(1), 80. Cited by: 31

  4. Shah, D. A., Gondalia, I. I., Patel, V. B., Mahajan, A., & Chhalotiya, U. K. (2020). Stability indicating liquid chromatographic method for the estimation of remogliflozin etabonate. Journal of Chemical Metrology, 14(2), 125–132. Cited by: 31

  5. Choudhary, D. R., Patel, V. A., Chhalotiya, U. K., Patel, H. V., & Kundawala, A. J. (2011). Formulation and evaluation of fast dissolving film of levocetirizine dihydrochloride using different grades of methocel. Journal of Pharmacy Research, 4(9), 2919–2924.Cited by: 29

Iram Iqbal | Cardiovascular Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Ms. Iram Iqbal | Cardiovascular Pharmacology | Best Researcher Award

PHD Scholar at Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Pakistan

Dr. Iram Iqbal, a dedicated pharmacology researcher and academic, has made significant contributions to ethnopharmacology, pharmaceutical quality assurance, and drug development. With a Pharm.D., M.Phil., and ongoing Ph.D. from Bahauddin Zakariya University, her research explores the pharmacological potential of medicinal plants and modern drug delivery mechanisms. She has served in multiple professional roles, including as a Drug Analyst at the Primary & Secondary Healthcare Department and as a lecturer, demonstrating expertise in pharmaceutical instrumentation and quality control aligned with ISO 17025 standards. Dr. Iqbal has published extensively in peer-reviewed journals, contributed book chapters, and presented at numerous national and international conferences. Her technical proficiency with instruments such as HPLC, GC-MS, and FTIR, coupled with her strong communication and organizational skills, underscores her commitment to scientific excellence. Passionate about continuous learning and societal impact, she stands as a strong candidate for the Best Researcher Award, though further international collaborations could enhance her global academic reach.

Professional Profile

Education🎓

Dr. Iram Iqbal has pursued a progressive and research-oriented academic path in the field of pharmacology. She earned her Doctor of Pharmacy (Pharm.D.) degree in 2010 from Bahauddin Zakariya University (BZU), Multan, Pakistan, laying a solid foundation in pharmaceutical sciences. Driven by a passion for research, she completed her M.Phil. in Pharmacology from the same institution in 2015, during which she deepened her understanding of drug mechanisms and medicinal plant pharmacology. Currently, she is enrolled in a Ph.D. program in Pharmacology at BZU, where her research focuses on exploring bioactive compounds in medicinal plants and their therapeutic potentials. Her education has been marked by academic excellence, practical exposure, and a commitment to integrating traditional medicine with modern pharmacological techniques. Throughout her academic journey, Dr. Iqbal has demonstrated a consistent dedication to advancing knowledge in pharmaceutical sciences, positioning herself as a capable researcher and educator in the evolving field of pharmacology.

Professional Experience📝

Dr. Iram Iqbal has accumulated over a decade of professional experience in academia and research, primarily in the field of pharmacology. She began her career as a Lecturer in the Department of Pharmacology at the Faculty of Pharmacy, Bahauddin Zakariya University (BZU), Multan, where she has played a vital role in teaching and mentoring pharmacy students. Her professional journey is marked by a strong emphasis on research, particularly in the areas of medicinal plants, pharmacological screening, and drug safety. Dr. Iqbal has been actively involved in supervising undergraduate and postgraduate research projects, contributing to the development of new insights in pharmacology. Her work also includes collaborations on national and international research projects, participation in scientific conferences, and the publication of several research articles in peer-reviewed journals. Her blend of academic teaching and hands-on research experience has established her as a respected professional committed to advancing pharmaceutical education and therapeutic innovation.

Research Interest🔎

Dr. Iram Iqbal’s research interests lie at the intersection of pharmacology, natural product research, and drug safety. She is particularly passionate about exploring the pharmacological properties of medicinal plants and evaluating their therapeutic potential in treating various diseases. Her focus includes the isolation and characterization of bioactive compounds, understanding their mechanisms of action, and assessing their efficacy and toxicity through preclinical studies. Dr. Iqbal is also interested in the pharmacovigilance and safety profiles of both conventional and herbal medicines, aiming to ensure their safe use in clinical practice. Her work often integrates traditional knowledge with modern scientific techniques, promoting evidence-based validation of herbal remedies. She has contributed significantly to the field through her research publications, and her projects often address contemporary health challenges, such as metabolic disorders, inflammation, and infectious diseases. Through her innovative and multidisciplinary approach, Dr. Iqbal seeks to contribute to the development of safer and more effective therapeutic agents.

Award and Honor🏆

Dr. Iram Iqbal has received several awards and honors in recognition of her outstanding contributions to pharmaceutical sciences and education. Her dedication to academic excellence and impactful research has earned her prestigious accolades at both national and institutional levels. She has been honored with research appreciation certificates and excellence awards from renowned academic bodies and universities. Her scholarly work, particularly in the field of pharmacology and natural product research, has been acknowledged through best paper awards and invitations to present at esteemed scientific conferences. In addition to her research achievements, Dr. Iqbal has been recognized for her exceptional teaching and mentorship, guiding numerous students in their academic and professional journeys. Her commitment to advancing pharmaceutical education and her role in shaping future scientists and researchers have further strengthened her reputation in the academic community. These honors reflect her dedication, integrity, and impact in both research and teaching within the field of pharmacy.

Research Skill🔬

Dr. Iram Iqbal possesses a diverse and robust set of research skills that reflect her expertise in pharmaceutical sciences and pharmacology. She is proficient in designing and conducting both in vitro and in vivo experiments, particularly in the evaluation of natural products for therapeutic use. Her skills include phytochemical screening, drug formulation development, pharmacological activity assessment, and toxicity profiling. Dr. Iqbal is well-versed in utilizing advanced laboratory techniques such as chromatography, spectrophotometry, and microscopy. She also demonstrates strong capabilities in data analysis using statistical software, ensuring accurate interpretation and presentation of research findings. Her ability to conduct systematic literature reviews and synthesize existing knowledge into innovative research proposals highlights her analytical thinking. Moreover, she excels in academic writing, having authored multiple peer-reviewed publications. Her collaborative skills and experience in multidisciplinary research projects further strengthen her ability to contribute meaningfully to scientific advancements in the field of pharmaceutical and biomedical research.

Conclusion💡

Dr. Iram Iqbal possesses a robust academic foundation, diverse research contributions, technical expertise, and a strong national impact, making her highly suitable for the Best Researcher Award. While her portfolio is already compelling, strategic enhancements—particularly in international collaborations, publication strategy, and funding leadership—could further elevate her profile globally.

Publications Top Noted✍️

  • Iqbal, I., Ali, M. A. M., Saqib, F., Alamgir, K., Mubarak, M. S., Chaudhary, A. A., El-Shazly, M., & El-Nashar, H. A. S. (2025). Comprehensive GC-MS profiling and multi-modal pharmacological evaluations of Haloxylon griffithii: In vitro and in vivo approaches. Pharmaceuticals, 18(6), Article 770. https://doi.org/10.3390/ph18060770

    Citation Index: Not available yet (published May 22, 2025; newly released).

  • Iqbal, I., Wilairatana, P., Saqib, F., Nasir, B., Wahid, M., Latif, M. F., Iqbal, A., Naz, R., & Mubarak, M. S. (2023). Plant polyphenols and their potential benefits on cardiovascular health: A review. Molecules, 28(17), 6403. https://doi.org/10.3390/molecules28176403

    Citation Index: According to Crossref, this article has 9 citations as of now.

Mitra Hosseini | Drug Delivery | Best Researcher Award

Published on by Global Scholar Awards

Ms. Mitra Hosseini | Drug Delivery | Best Researcher Award

PhD Candidate at University of South Australia, Australia

Mahboubeh (Mitra) Hosseini-Kharat is a Ph.D. student at the University of South Australia specializing in vaccine development and gene expression research. Her research focuses on designing lipid-based nanocarriers for efficient gene delivery and nucleic acid-based cancer vaccines, employing advanced techniques such as microfluidic mixing, fluorescence microscopy, and flow cytometry. Hosseini-Kharat possesses strong analytical, problem-solving, and organizational skills, excelling in scientific writing, grant applications, and project management. She has received several prestigious awards, including the Global Talent Visa (Australia) and research grants from the Iran National Science Foundation. She has contributed significantly to various research projects in nanomedicine, cancer therapy, and vaccine formulations, with a focus on improving drug delivery systems. Her notable publications include several high-impact papers in respected journals such as Pharmaceutics and Molecular Therapy: Methods & Clinical Development. With extensive teaching and mentoring experience, she is a highly promising researcher in her field.

Professional Profile 

Education🎓

Mahboubeh (Mitra) Hosseini-Kharat has an extensive academic background in the fields of pharmacy and pharmaceutical sciences. She completed her Bachelor’s degree in Pharmaceutical Sciences from the University of Medical Sciences in Iran. Following that, she pursued a Master’s degree in Pharmaceutics at the same institution, where she gained a strong foundation in drug formulation, delivery systems, and nanomedicine. Hosseini-Kharat’s passion for advanced research led her to continue her academic journey as a Ph.D. candidate at the University of South Australia, where she is currently working on vaccine development and gene expression research. Her doctoral research focuses on designing lipid-based nanocarriers for gene delivery and nucleic acid-based cancer vaccines. This progression from a Bachelor’s to a Ph.D. has equipped her with a deep understanding of pharmaceutical sciences and advanced techniques in drug delivery and cancer therapy, furthering her expertise in nanomedicine and vaccine development.

Professional Experience📝

Mahboubeh (Mitra) Hosseini-Kharat has built a solid professional career in the field of pharmaceutical sciences, particularly in drug delivery and nanomedicine. After completing her Master’s degree in Pharmaceutics, she contributed to several research projects involving drug formulation and delivery systems. Her expertise further expanded during her role as a research assistant, where she investigated the potential of lipid-based nanocarriers for targeted drug delivery. Currently, Hosseini-Kharat is pursuing her Ph.D. at the University of South Australia, focusing on the development of gene-based vaccines and gene expression regulation. Her research aims to enhance vaccine efficacy and design innovative drug delivery systems to address complex diseases, including cancer. Along with her academic research, she has also participated in various scientific collaborations, contributing to the growing field of nanomedicine. Her professional experience highlights her dedication to advancing pharmaceutical sciences and her commitment to impactful research in healthcare innovation.

Research Interest🔎

Mahboubeh (Mitra) Hosseini-Kharat’s research interests focus on advancing pharmaceutical sciences, particularly in the areas of drug delivery, nanomedicine, and gene therapy. Her work explores the design and development of novel drug delivery systems, with a particular emphasis on lipid-based nanocarriers and their application in targeted drug delivery. She is dedicated to improving the efficacy of therapeutic agents, especially in the treatment of complex diseases like cancer. Currently, her Ph.D. research at the University of South Australia focuses on the development of gene-based vaccines and the regulation of gene expression to enhance immune responses and vaccine efficacy. Additionally, Hosseini-Kharat is deeply interested in the intersection of nanotechnology and medicine, aiming to create innovative solutions that can overcome the limitations of traditional drug delivery systems. Her research seeks to contribute to more effective and personalized treatments, fostering advancements in healthcare and therapeutic modalities.

Award and Honor🏆

Mahboubeh (Mitra) Hosseini-Kharat has received several prestigious awards and honors throughout her academic career, recognizing her outstanding contributions to pharmaceutical sciences and research. She was honored with a scholarship from the University of South Australia for her exceptional academic achievements and research potential. Additionally, her work on novel drug delivery systems has earned her multiple accolades, including recognition at various international conferences, where she presented groundbreaking findings on lipid-based nanocarriers and gene therapy. Hosseini-Kharat’s research has been praised for its potential to revolutionize cancer treatment and improve drug efficacy. She has also been awarded research grants and fellowships to support her work in the field of nanomedicine and gene-based vaccines. Her recognition highlights her commitment to advancing healthcare, with a particular focus on creating more effective and personalized treatment options through the integration of nanotechnology and pharmaceutical sciences.

Research Skill🔬

Mahboubeh (Mitra) Hosseini-Kharat possesses a diverse and advanced set of research skills in the field of pharmaceutical sciences, particularly in drug delivery systems and nanomedicine. She has a strong command over various laboratory techniques, including nanoparticle formulation, lipid-based nanocarriers, and gene delivery systems. Her proficiency in using state-of-the-art analytical tools, such as high-performance liquid chromatography (HPLC) and scanning electron microscopy (SEM), allows her to evaluate the stability, size, and release profiles of drug formulations. Additionally, Hosseini-Kharat is skilled in the preparation and testing of in vitro and in vivo models for evaluating drug efficacy and safety. Her expertise extends to the design and synthesis of innovative pharmaceutical formulations, as well as the development of gene-based vaccines. She is also adept at utilizing bioinformatics tools for data analysis, ensuring that her research findings are both accurate and meaningful. Her multidisciplinary approach reflects a high level of technical expertise and creativity in pharmaceutical research.

Conclusion💡

Mitra Hosseini-Kharat demonstrates exceptional strength as a researcher in the field of pharmaceutical sciences, particularly in vaccine development and gene expression. Her combination of innovative research, strong publication record, grant funding, and collaborative skills positions her as a strong candidate for the Best Researcher Award. While there are areas for growth, particularly in broadening her research exposure and increasing public engagement, her academic achievements and potential for future contributions make her a highly suitable candidate for this prestigious award.

Publications Top Noted✍️

  • Title: Microfluidic Optimization of PEI-Lipid Hybrid Nanoparticles for Efficient DNA Delivery and Transgene Expression
    Authors: M Hosseini Kharat, Anthony Wignall, Zelalem Addis Mekonnen, Benjamin Ung, Bradley Chereda, Kristen Bremmell, Branka Grubor-Bauk, Clive Prestidge
    Year: 2025
    Citation: DOI: 10.3390/pharmaceutics17040454

  • Title: Improvement of Power Conversion Efficiency of Quantum Dot-Sensitized Solar Cells by Doping of Manganese into a ZnS Passivation Layer and Cosensitization of Zinc-Porphyrin on a Modified Graphene Oxide/Nitrogen-Doped TiO<sub>2</sub> Photoanode
    Authors: M. Alavi, R. Rahimi, Z. Maleki, M. Hosseini-Kharat
    Year: 2020
    Citation: DOI: 10.1021/acsomega.0c00855

  • Title: Antiproliferative activity of morpholine-based compounds on MCF-7 breast cancer, colon carcinoma C26, and normal fibroblast NIH-3T3 cell lines and study of their binding affinity to calf thymus-DNA and bovine serum albumin
    Authors: M. Hosseini-Kharat, R. Rahimi, D. Zargarian, Z. Mehri Lighvan, A.A. Momtazi-Borojeni, T. Sharifi, E. Abdollahi, H. Tavakol, T. Mohammadi
    Year: 2019
    Citation: DOI: 10.1080/07391102.2018.1527724

  • Title: In vitro and in vivo antiproliferative activity of organo-nickel SCS-pincer complexes on estrogen responsive MCF7 and MC4L2 breast cancer cells. Effects of amine fragment substitutions on BSA binding and cytotoxicity
    Authors: M. Hosseini-Kharat, D. Zargarian, A.M. Alizadeh, K. Karami, M. Saeidifar, S. Khalighfard, L. Dubrulle, M. Zakariazadeh, J.-P. Cloutier, Z. Sohrabijam
    Year: 2018
    Citation: DOI: 10.1039/C8DT03079K

  • Title: A novel Pd(II) CNO pincer complex of MR (methyl red): synthesis, crystal structure, interaction with human serum albumin (HSA) in vitro and molecular docking
    Authors: M. Hosseini-Kharat
    Year: 2017
    Citation: DOI: 10.1039/C7NJ02156D

  • Title: NC Palladacycles and C,C-chelating phosphorus ylide complexes: Synthesis, X-ray characterization, and comparison of the catalytic activity in the Suzuki-Miyaura reaction
    Authors: K. Karami, M. Hosseini-Kharat, Z. Shirani-Sarmazeh, R. Zahedi-Nasab, C. Rizzoli, J. Lipkowski
    Year: 2016
    Citation: DOI: 10.1080/00958972.2016.1151876

  • Title: Synthesis, spectral characterization, crystal structure and in vitro DNA/protein binding studies of phosphorous ylide palladacyclic complexes containing azide group
    Authors: K. Karami, Z. Shirani-Sarmazeh, M. Hosseini-Kharat, J. Lipkowski, M. Saeidifar
    Year: 2015
    Citation: DOI: 10.1016/j.jphotobiol.2015.01.012

  • Title: In vitro cytotoxicity studies of palladacyclic complexes containing the symmetric diphosphine bridging ligand. Studies of their interactions with DNA and BSA
    Authors: K. Karami, M. Hosseini-Kharat, H. Sadeghi-Aliabadi, J. Lipkowski, M. Mirian
    Year: 2014
    Citation: DOI: 10.1016/j.ejmech.2013.11.042

  • Title: Polyethylene glycol-supported recyclable NC palladacycle catalyst for Heck cross-coupling reactions
    Authors: K. Karami, Z.K. Moghadam, M. Hosseini-Kharat
    Year: 2014
    Citation: DOI: 10.1016/j.catcom.2013.08.027

  • Title: Structural and theoretical studies of mono and di-insertion of symmetric alkynes into the Pd-C σ bond of cyclopalladated secondary (tert-butyl and ethyl) benzylamines
    Authors: K. Karami, M. Hosseini-Kharat, C. Rizzoli, H. Tavakol, J. Lipkowski
    Year: 2014
    Citation: DOI: 10.1016/j.jorganchem.2013.11.030

Ho Lini | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

🌟Prof Dr. Ho Lini, Pharmacology, Best Researcher Award🏆

Professor at National Chung Hsing University, Taiwan

Ho Lin (Jack, 林 赫) is an accomplished scientist and educator with expertise in cell biology, neurobiology, pharmacology, reproduction, endocrinology, and cancer biology. Currently serving as the Executive Director of the Science & Technology Division at the Taipei Economic & Cultural Office in Australia and a Distinguished Professor at the Department of Life Sciences, National Chung Hsing University (NCHU), Taiwan, Ho Lin has made significant contributions to the field of biomedical research through his academic pursuits, administrative roles, and collaborative projects. With a background in physiology from National Yang Ming University and biology from Tunghai University, Ho Lin has a strong foundation in both theoretical knowledge and practical research methodologies.

Author Metrics:

Ho Lin has a prolific publication record, with numerous articles published in prestigious scientific journals. As an established researcher, he has contributed to advancing scientific knowledge in various areas of biology and medicine. His publications have been cited extensively, reflecting the impact of his work within the scientific community. Additionally, Ho Lin’s expertise is recognized through his editorial roles in esteemed journals and his participation in scholarly activities such as peer review and guest editing.

Scopus Profile

ORCID Profile

Citations: 2,207 across 1,858 documents

h-index: 27

Number of Documents Authored: 85

Education:

Ho Lin earned his Doctor of Philosophy (Ph.D.) in Physiology from National Yang Ming University and his Bachelor of Science (B.S.) in Biology from Tunghai University. His academic journey provided him with a solid foundation in biomedical sciences, shaping his subsequent career in research and academia. Through rigorous training and interdisciplinary studies, Ho Lin developed expertise in multiple fields, enabling him to conduct innovative research and mentor aspiring scientists.

Research Focus:

Ho Lin’s research interests encompass hormone receptors in cancer biology, novel functions of hormone receptors, and neurobiology. His investigations aim to unravel the molecular mechanisms underlying disease pathogenesis and identify potential therapeutic targets. By elucidating the roles of hormone receptors in cancer progression and exploring their diverse functions in physiological processes, Ho Lin contributes to the development of novel treatment strategies and diagnostic tools.

Professional Journey:

Ho Lin’s professional journey spans various academic and administrative roles, reflecting his commitment to advancing scientific knowledge and fostering academic excellence. From his early career as a postdoctoral fellow at the National Health Research Institutes to his current positions as an Executive Director and Distinguished Professor, Ho Lin has demonstrated leadership, expertise, and dedication to his field. His contributions to education, research, and institutional governance have earned him recognition and respect within the scientific community.

Honors & Awards:

Throughout his career, Ho Lin has received numerous honors and awards in recognition of his outstanding contributions to science and academia. These accolades include the NCHU Distinguished Professorship, Distinguished Mentorship, and grants for distinguished young scholars. Ho Lin’s achievements reflect his excellence in research, teaching, and mentorship, inspiring future generations of scientists and contributing to the advancement of biomedical sciences.

Publications Noted & Contributions:

Ho Lin’s publications are noted for their significance in advancing scientific knowledge and addressing critical questions in biology and medicine. His research contributions span a wide range of topics, including hormone receptor signaling, cancer biology, neurobiology, and pharmacology. Through his publications, Ho Lin has disseminated novel findings, proposed innovative hypotheses, and contributed to the scientific discourse on various biological processes and disease mechanisms.

Metformin alters dendrite development and synaptic plasticity in rat cortical neurons

Published in Biochemical and Biophysical Research Communications, May 2024.

DOI: 10.1016/j.bbrc.2024.149874

Contributors: Muhammet Oner, Pang-Ting Cheng, Hsin-Yi Wang, Mei-Chih Chen, Ho Lin

Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1/STAT3/MYC pathways

Published in Toxicology in Vitro, December 2023.

DOI: 10.1016/j.tiv.2023.105768

Contributors: Chieh-Lin Jerry Teng, Pang-Ting Cheng, Yu-Chiao Cheng, Jia-Rung Tsai, Mei-Chih Chen, Ho Lin

RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells

Published in American Journal of Physiology-Cell Physiology, November 1, 2023.

DOI: 10.1152/ajpcell.00494.2022

Contributors: Wan-Ling Liao, Ho Lin, Yu-Hsuan Li, Tsung-Ying Yang, Mei-Chih Chen

Impacts of androgen pathway manipulation on patients with lung cancer

Published in Journal of Clinical Oncology, June 1, 2023.

DOI: 10.1200/jco.2023.41.16_suppl.e21010

Contributors: Po-Hsin Lee, Jeng-Sen Tseng, Yen-Hsiang Huang, Yu-Wei Hsu, Kuo-Hsuan Hsu, Tsung-Ying Yang, Ho Lin

Abstract A12: Androgen receptor inhibition is involved in Finasteride-reduced AML cell proliferation

Published in Blood Cancer Discovery, May 1, 2023.

DOI: 10.1158/2643-3249.aml23-a12

Contributors: Pang-Ting Cheng, Chieh-Lin Jerry Teng, Yu-Chiao Cheng, Mei-Chih Chen, Ho Lin

Research Timeline:

Ho Lin’s research timeline reflects a progressive trajectory characterized by continuous growth, innovation, and collaboration. From his early explorations as a graduate student to his current leadership roles, Ho Lin’s research journey has been marked by significant achievements, breakthroughs, and interdisciplinary collaborations. Through a combination of basic and translational research, Ho Lin has made notable contributions to understanding disease pathogenesis and developing therapeutic interventions.

Collaborations and Projects:

Ho Lin has actively engaged in collaborative projects with researchers and institutions worldwide, leveraging collective expertise and resources to address complex scientific challenges. His collaborations encompass multidisciplinary teams and interdisciplinary approaches, fostering innovation and knowledge exchange. By collaborating with diverse stakeholders, Ho Lin promotes synergistic research efforts and accelerates the translation of scientific discoveries into clinical applications.